Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

April 01, 2015; Volume 43,Issue 4

Perspective

  • You have access
    Contribution of Metabolites to P450 Inhibition–Based Drug–Drug Interactions: Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group
    Hongbin Yu, Suresh K. Balani, Weichao Chen, Donghui Cui, Ling He, W. Griffith Humphreys, Jialin Mao, W. George Lai, Anthony J. Lee, Heng-Keang Lim, Christopher MacLauchlin, Chandra Prakash, Sekhar Surapaneni, Susanna Tse, Alana Upthagrove, Robert L. Walsky, Bo Wen and Zhaopie Zeng
    Drug Metabolism and Disposition April 2015, 43 (4) 620-630; DOI: https://doi.org/10.1124/dmd.114.059345

Minireview

  • You have access
    Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design
    Caroline A. Lee, Meeghan A. O’Connor, Tasha K. Ritchie, Aleksandra Galetin, Jack A. Cook, Isabelle Ragueneau-Majlessi, Harma Ellens, Bo Feng, Mitchell E. Taub, Mary F. Paine, Joseph W. Polli, Joseph A. Ware and Maciej J. Zamek-Gliszczynski
    Drug Metabolism and Disposition April 2015, 43 (4) 490-509; DOI: https://doi.org/10.1124/dmd.114.062174

Short Communications

  • You have access
    Associations of HSD11B1 Polymorphisms with Tacrolimus Concentrations in Chinese Renal Transplant Recipients with Prednisone Combined Therapy
    Xiaoman Liu, Jiali Li, Qian Fu, Shu Liu, Yu Zhang, Xueding Wang, Hongyang Wang, Jun Li, Chen Zhu, Changxi Wang and Min Huang
    Drug Metabolism and Disposition April 2015, 43 (4) 455-458; DOI: https://doi.org/10.1124/dmd.114.062117
  • You have access
    Impact on Creatinine Renal Clearance by the Interplay of Multiple Renal Transporters: A Case Study with INCB039110
    Yan Zhang, Mark S. Warren, Xuexiang Zhang, Sharon Diamond, Bill Williams, Naresh Punwani, Jane Huang, Yong Huang and Swamy Yeleswaram
    Drug Metabolism and Disposition April 2015, 43 (4) 485-489; DOI: https://doi.org/10.1124/dmd.114.060673

Accelerated Communication

  • You have access
    PBPK Modeling to Unravel Nonlinear Pharmacokinetics of Verapamil to Estimate the Fractional Clearance for Verapamil N-Demethylation in the Recirculating Rat Liver Preparation
    Qi Joy Yang, Luqin Si, Hui Tang, Helle H. Sveigaard, Edwin C. Y. Chow and K. Sandy Pang
    Drug Metabolism and Disposition April 2015, 43 (4) 631-645; DOI: https://doi.org/10.1124/dmd.114.062265

Articles

  • You have access
    Meta-Analysis of Expression of Hepatic Organic Anion–Transporting Polypeptide (OATP) Transporters in Cellular Systems Relative to Human Liver Tissue
    Justine Badée, Brahim Achour, Amin Rostami-Hodjegan and Aleksandra Galetin
    Drug Metabolism and Disposition April 2015, 43 (4) 424-432; DOI: https://doi.org/10.1124/dmd.114.062034
  • You have access
    Characterization of Chrysin Glucuronidation in UGT1A1-Overexpressing HeLa Cells: Elucidating the Transporters Responsible for Efflux of Glucuronide
    Enxi Quan, Huailing Wang, Dong Dong, Xingwang Zhang and Baojian Wu
    Drug Metabolism and Disposition April 2015, 43 (4) 433-443; DOI: https://doi.org/10.1124/dmd.114.061598
  • You have access
    Mechanism-Based Inhibitory and Peroxisome Proliferator-Activated Receptor α–Dependent Modulating Effects of Silybin on Principal Hepatic Drug-Metabolizing Enzymes
    Hong Wang, Tingting Yan, Yuan Xie, Min Zhao, Yuan Che, Jun Zhang, Huiying Liu, Lijuan Cao, Xuefang Cheng, Yang Xie, Feiyan Li, Qu Qi, Guangji Wang and Haiping Hao
    Drug Metabolism and Disposition April 2015, 43 (4) 444-454; DOI: https://doi.org/10.1124/dmd.114.061622
  • You have access
    Utility of Bilirubins and Bile Acids as Endogenous Biomarkers for the Inhibition of Hepatic Transporters
    Tomoko Watanabe, Manami Miyake, Toshinobu Shimizu, Miho Kamezawa, Naoya Masutomi, Takesada Shimura and Rikiya Ohashi
    Drug Metabolism and Disposition April 2015, 43 (4) 459-466; DOI: https://doi.org/10.1124/dmd.114.061051
  • You have access
    Conjugation and Deconjugation Reactions within the Fetoplacental Compartment in a Sheep Model: A Key Factor Determining Bisphenol A Fetal Exposure
    Tanguy Corbel, Elisabeth Perdu, Véronique Gayrard, Sylvie Puel, Marlène Z. Lacroix, Catherine Viguié, Pierre-Louis Toutain, Daniel Zalko and Nicole Picard-Hagen
    Drug Metabolism and Disposition April 2015, 43 (4) 467-476; DOI: https://doi.org/10.1124/dmd.114.061291
  • You have access
    Dipeptidyl Peptidase-4 Greatly Contributes to the Hydrolysis of Vildagliptin in Human Liver
    Mitsutoshi Asakura, Hideaki Fujii, Koichiro Atsuda, Tomoo Itoh and Ryoichi Fujiwara
    Drug Metabolism and Disposition April 2015, 43 (4) 477-484; DOI: https://doi.org/10.1124/dmd.114.062331
  • You have access
    Physiologically Based Pharmacokinetic Modeling for Sequential Metabolism: Effect of CYP2C19 Genetic Polymorphism on Clopidogrel and Clopidogrel Active Metabolite Pharmacokinetics
    Nassim Djebli, David Fabre, Xavier Boulenc, Gérard Fabre, Eric Sultan and Fabrice Hurbin
    Drug Metabolism and Disposition April 2015, 43 (4) 510-522; DOI: https://doi.org/10.1124/dmd.114.062596
  • You have access
    A Long-Standing Mystery Solved: The Formation of 3-Hydroxydesloratadine Is Catalyzed by CYP2C8 But Prior Glucuronidation of Desloratadine by UDP-Glucuronosyltransferase 2B10 Is an Obligatory Requirement
    Faraz Kazmi, Joanna E. Barbara, Phyllis Yerino and Andrew Parkinson
    Drug Metabolism and Disposition April 2015, 43 (4) 523-533; DOI: https://doi.org/10.1124/dmd.114.062620
  • You have access
    Hydrastine Pharmacokinetics and Metabolism after a Single Oral Dose of Goldenseal (Hydrastis canadensis) to Humans
    Prem K. Gupta, Gary Barone, Bill J. Gurley, E. Kim Fifer and Howard P. Hendrickson
    Drug Metabolism and Disposition April 2015, 43 (4) 534-552; DOI: https://doi.org/10.1124/dmd.114.059410
  • You have access
    Structural Modifications at the C-4 Position Strongly Affect the Glucuronidation of 6,7-Dihydroxycoumarins
    Yang-Liu Xia, Guang-Bo Ge, Ping Wang, Si-Cheng Liang, Yu-Qi He, Jing Ning, Xing-Kai Qian, Yan Li and Ling Yang
    Drug Metabolism and Disposition April 2015, 43 (4) 553-560; DOI: https://doi.org/10.1124/dmd.114.060681
  • You have access
    In Vitro and In Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population
    Guo-Xin Hu, Pei-Pei Pan, Zeng-Shou Wang, Li-Ping Yang, Da-Peng Dai, Shuang-Hu Wang, Guang-Hui Zhu, Xiang-Jun Qiu, Tao Xu, Jun Luo, Qing-Quan Lian, Ren-Shan Ge and Jian-Ping Cai
    Drug Metabolism and Disposition April 2015, 43 (4) 561-569; DOI: https://doi.org/10.1124/dmd.114.061200
  • You have access
    Enantioselective Pharmacokinetics of Primaquine in Healthy Human Volunteers
    Babu L. Tekwani, Bharathi Avula, Rajnish Sahu, Narayan D. Chaurasiya, Shabana I. Khan, Surendra Jain, Pius S. Fasinu, H.M.T. Bandara Herath, Donald Stanford, N.P. Dhammika Nanayakkara, James D. McChesney, Travis W. Yates, Mahmoud A. ElSohly, Ikhlas A. Khan and Larry A. Walker
    Drug Metabolism and Disposition April 2015, 43 (4) 571-577; DOI: https://doi.org/10.1124/dmd.114.061127
  • You have access
    Identification of Glutathione Conjugates of Acetylene-Containing Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5
    Xiaoliang Zhuo, Xiaohua Stella Huang, Andrew P. Degnan, Lawrence B. Snyder, Fukang Yang, Hong Huang, Yue-Zhong Shu and Benjamin M. Johnson
    Drug Metabolism and Disposition April 2015, 43 (4) 578-589; DOI: https://doi.org/10.1124/dmd.114.061879
  • You have access
    A New Physiologically Based Pharmacokinetic Model for the Prediction of Gastrointestinal Drug Absorption: Translocation Model
    Hirotaka Ando, Akihiro Hisaka and Hiroshi Suzuki
    Drug Metabolism and Disposition April 2015, 43 (4) 590-602; DOI: https://doi.org/10.1124/dmd.114.060038
  • You have access
    Generation of Enterocyte-Like Cells with Pharmacokinetic Functions from Human Induced Pluripotent Stem Cells Using Small-Molecule Compounds
    Takahiro Iwao, Nao Kodama, Yuki Kondo, Tomoki Kabeya, Katsunori Nakamura, Takashi Horikawa, Takuro Niwa, Kouichi Kurose and Tamihide Matsunaga
    Drug Metabolism and Disposition April 2015, 43 (4) 603-610; DOI: https://doi.org/10.1124/dmd.114.062604
  • You have access
    Quantitative Profiling of Human Renal UDP-glucuronosyltransferases and Glucuronidation Activity: A Comparison of Normal and Tumoral Kidney Tissues
    Guillaume Margaillan, Michèle Rouleau, John K. Fallon, Patrick Caron, Lyne Villeneuve, Véronique Turcotte, Philip C. Smith, Melanie S. Joy and Chantal Guillemette
    Drug Metabolism and Disposition April 2015, 43 (4) 611-619; DOI: https://doi.org/10.1124/dmd.114.062877

Erratum

  • You have access
    Correction to: “Imperatorin Is a Mechanism-Based Inactivator of CYP2B6”
    Drug Metabolism and Disposition April 2015, 43 (4) 570; DOI: https://doi.org/10.1124/dmd.115.060558err
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 43 (4)
Drug Metabolism and Disposition
Vol. 43, Issue 4
1 Apr 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Perspective
  • Minireview
  • Short Communications
  • Accelerated Communication
  • Articles
  • Erratum
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics